Drug name - Zetonna

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8371292 COVIS Use of ciclesonide for the treatment of respiratory diseases Feb, 2028

(5 years from now)

Drugs and Companies using CICLESONIDE ingredient

Treatment: Treatment of symptoms associated with seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older. patent claims methods for treating a respiratory disease in a child

Dosage: AEROSOL, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
0.037MG/INH AEROSOL, METERED;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.